Ligand validation:6KS1

OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLB is a Ligand Of Interest in 6KS1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6KS1_OLB_A_407	3%	96%	0.321	0.675	0.19	0.17	-	-	5	0	100%	1
6KS1_OLB_A_403	2%	95%	0.36	0.634	0.21	0.2	-	-	1	0	100%	1
6KS1_OLB_A_406	1%	96%	0.507	0.671	0.21	0.17	-	-	0	0	100%	1
6KS1_OLB_A_404	1%	96%	0.375	0.571	0.18	0.16	-	-	0	0	76%	0.76
6KS1_OLB_A_405	1%	96%	0.449	0.556	0.2	0.17	-	-	2	0	100%	1
5LWY_OLB_A_402	13%	95%	0.234	0.777	0.18	0.23	-	-	1	0	100%	1
4KPP_OLB_A_502	41%	46%	0.17	0.892	1.07	1.02	2	1	0	0	96%	0.96
5LX9_OLB_A_409	37%	93%	0.177	0.876	0.19	0.3	-	-	1	0	100%	0.64
6XLP_OLB_A_616	34%	61%	0.182	0.908	0.8	0.69	-	-	1	0	76%	0.76
5IUB_OLB_A_2421	34%	53%	0.166	0.898	0.93	0.89	2	1	0	0	72%	0.72
7AVN_OLB_B_314	34%	39%	0.105	0.863	1.2	1.18	1	1	3	0	56%	0.56

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.